Noomie Lam
YOU?
Author Swipe
View article: A morphometric signature to identify ductal carcinoma in situ with a low risk of progression
A morphometric signature to identify ductal carcinoma in situ with a low risk of progression Open
View article: Artificial intelligence-based morphometric signature to identify ductal carcinoma in situ with low risk of progression to invasive breast cancer
Artificial intelligence-based morphometric signature to identify ductal carcinoma in situ with low risk of progression to invasive breast cancer Open